Feedback / Questions
ATRC-101 - Atreca
Keytruda (pembrolizumab) - Merck (MSD)
https://www.globenewswire.com/news-release/2021/07/29/2271117/0/en/Atreca-Presents-Initial-Clinical-Data-from-Phase-1b-Trial-of-ATRC-101-in-Select-Advanced-Solid-Tumors.html
Jul 29, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next